Publication | Closed Access

Updated Overall Survival Analysis From IMpower110: Atezolizumab Versus Platinum-Based Chemotherapy in Treatment-Naive Programmed Death-Ligand 1–Selected NSCLC

MedicinePharmacologyImmune Checkpoint InhibitorPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyLung CancerMolecular Oncology